These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25636416)

  • 1. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.
    Kim TH; Jeong JY; Lee SW; Kim CK; Park BK; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    Eur Radiol; 2015 Jun; 25(6):1786-92. PubMed ID: 25636416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.
    Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
    J Urol; 2013 Oct; 190(4):1213-7. PubMed ID: 23727188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.
    Henderson DR; de Souza NM; Thomas K; Riches SF; Morgan VA; Sohaib SA; Dearnaley DP; Parker CC; van As NJ
    Eur Urol; 2016 Jun; 69(6):1028-33. PubMed ID: 26482887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion-weighted imaging for prostate cancer localization: comparison of apparent diffusion coefficient values in cancerous and non-cancerous tissues, and the Gleason score of the radical prostatectomy specimens].
    Kobayashi H; Kitamura K; Mizukami S; Hanazawa K; Sakamoto Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):489-95. PubMed ID: 23819360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.
    Park SY; Kim CK; Park BK; Lee HM; Lee KS
    Eur Radiol; 2011 May; 21(5):1111-8. PubMed ID: 21046403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
    Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
    AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.
    Morgan VA; Riches SF; Thomas K; Vanas N; Parker C; Giles S; Desouza NM
    Br J Radiol; 2011 Jan; 84(997):31-7. PubMed ID: 21172965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy.
    Vasarainen H; Lahdensuo K; Savolainen R; Ruutu M; Taari K; Rannikko A
    Scand J Urol; 2013 Dec; 47(6):456-61. PubMed ID: 23327661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol.
    Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
    Jpn J Clin Oncol; 2013 May; 43(5):553-8. PubMed ID: 23580758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
    Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
    Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
    Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
    Costa DN; Xi Y; Aziz M; Passoni N; Shakir N; Goldberg K; Francis F; Roehrborn CG; Leon AD; Pedrosa I
    AJR Am J Roentgenol; 2019 Jan; 212(1):109-116. PubMed ID: 30383404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.